| | NorthShore
Q4 2012 | Decile Benchmark |
|
Acute Myocardial Infarction (Heart Attack Care)
|
|
|
|
 AMI-1 Aspirin at Arrival: % of acute myocardial infarction (AMI) patients without aspirin contraindications who received aspirin within 24 hours before or after hospital arrival
|
99.3%
|
100.0%
|
|
AMI-2 Aspirin Prescribed at Discharge: % of acute myocardial infarction (AMI) patients without aspirin contraindications who are prescribed aspirin at hospital discharge
|
99.3%
|
100.0%
|
|
AMI-3 ACEI or ARB for Left Ventricular Systolic Dysfunction: % of acute myocardial infarction (AMI) patients with left ventricular systolic dysfunction (LVSD) and without angiotensin converting enzyme inhibitor (ACEI) contraindications who are prescribed an ACEI at hospital discharge
|
100.0%
|
100.0%
|
|
AMI-5 Beta Blocker Prescribed at Discharge: % of acute myocardial infarction (AMI) patients without beta blocker contraindications who are prescribed a beta blocker at hospital discharge
|
100.0%
|
100.0%
|
|
AMI-8a PCI Received Within 90 Minutes of Hospital Arrival: % of eligible patients having a percutaneous cardiac intervention (PCI) within 90 minutes of arrival at the hospital
|
100.0%
|
100.0%
|
|
Heart Failure
|
|
|
|
HF-1 Discharge Instructions Received: % of eligible patients with heart failure receiving detailed instructions at discharge
|
100.0%
|
100.0%
|
|
HF-2 Left Ventricular Function Assessment: % of heart failure patients with documentation in the hospital record that left ventricular function (LVF) was assessed before arrival, during hospitalization, or planned for after discharge
|
100.0%
|
100.0%
|
|
HF-3 ACE Inhibitor for Left Ventricular Systolic Dysfunction: % of heart failure patients with left ventricular systolic dysfunction (LVSD) and without angiotensin converting enzyme inhibitor (ACEI) contraindications who are prescribed an ACEI at hospital discharge
|
100.0%
|
100.0%
|
|
Community Acquired Pneumonia
|
|
|
|
PN-3b Blood Cultures Performed Before First Antiobiotic Received: % of patients with community acquired pneumonia having blood culture tests performed before first antiobiotic was received
|
100.0%
|
100.0%
|
|
PN-6 Initial Antibiotic Selection for CAP in Immunocompetent Patients: % of patients with community acquired pneumonia whose initial antibiotic treatment was appropriate antibiotic
|
100.0%
|
99.0%
|
|
Surgical Infection Prevention (CABG, Other Cardiac, Colon, Hip and Knee Replacements, Hysterectomy, Vascular Surgeries)
|
|
|
|
SCIP-1 Prophylactic Antibiotic Received Within 1 Hour Prior to Surgical Incision: % of eligible surgical patients receiving prophylactic antibiotic (to prevent infection) within 1 hour prior to surgical incision
|
98.9%
|
100.0%
|
|
SCIP-2 Prophylactic Antibiotic Selection for Surgical Patients (Appropriate): % of eligible surgical patients who had an appropriate prophylactic antibiotic selected
|
99.2%
|
100.0%
|
|
SCIP-3 Prophylactic Antibiotics Discontinued Within 24 Hours After Surgery End Time: % of eligible surgical patients having prophylactic antibiotics discontinued within 24 hours after the end of surgery
|
99.2%
|
100.0%
|
|
SCIP-VTE-1 Recommended VTE (Blood Clot) Prophylaxis: % of patients with recommended venous thromboembolism prophylaxis ordered
|
98.6%
|
100.0%
|
|
SCIP-VTE-2 Received Appropriate VTE (Blood Clot) Prophylaxis: % of patients who received appropriate venous thromboembolism prophylaxis within 24 hours prior to surgery to 24 hours after surgery
|
96.4%
|
100.0%
|